TY - JOUR
T1 - Effects of a nurse-led transitional burns rehabilitation programme (4Cs-TBuRP) for adult burn survivors
T2 - protocol for a randomised controlled trial
AU - Bayuo, Jonathan
AU - Wong, Frances Kam Yuet
AU - Chung, Loretta Yuet Foon
N1 - Funding Information:
The authors will want to acknowledge the continued support offered by staff at the study site, the participants, and their families who will participate in the study. Recruitment is expected to commence in November 2020 and intended completion date is December 2022. Protocol amendment number 2. Amendment 01 (17/08/2020): Proper use of title case formats, removal of all in-text references, change in the study type and report on the maximum and minimum scores of all outcome measures. The Hong Kong Polytechnic University The trial sponsor had no role in the design of this study and will not have any role during its execution, analyses, interpretation of the data, or decision to submit results.
Publisher Copyright:
© 2021, The Author(s).
PY - 2021/12
Y1 - 2021/12
N2 - Background: Transitioning from the burn unit to the home/community can be chaotic with limited professional support. Some adult burn survivors may face varied concerns leading to poor outcomes in the early post-discharge period with limited access to professional help. Based on these, a nurse-led transitional burns rehabilitation programme has been developed and the current trial aims to ascertain its effects as well as explore the implementation process. Methods: A single-centre, double-arm randomised controlled trial with a process evaluation phase will be utilised for this study. All adult burn survivors aged ≥ 18 years with burn size ≥ 10% total burn surface area at the site during the study period will be screened for eligibility at least 72 h to discharge. A sample size of 150 will be block randomised to treatment (receiving the nurse-led transitional care programme and routine post-discharge service) and control groups (receiving routine post-discharge service). The nurse-led transitional care programme comprises of predischarge and follow-up phases with the delivery of bundle of holistic interventions lasting for 8 weeks. There are three timelines for data collection: baseline, immediate post intervention, and 4 weeks post-intervention. Discussion: The findings from this study can potentially inform the development and organisation of post-discharge care and affirm the need for ongoing comprehensive home-based care for burn survivors and their families Trial registration: ClinicalTrials.govNCT04517721. Registered on 20 August 2020
AB - Background: Transitioning from the burn unit to the home/community can be chaotic with limited professional support. Some adult burn survivors may face varied concerns leading to poor outcomes in the early post-discharge period with limited access to professional help. Based on these, a nurse-led transitional burns rehabilitation programme has been developed and the current trial aims to ascertain its effects as well as explore the implementation process. Methods: A single-centre, double-arm randomised controlled trial with a process evaluation phase will be utilised for this study. All adult burn survivors aged ≥ 18 years with burn size ≥ 10% total burn surface area at the site during the study period will be screened for eligibility at least 72 h to discharge. A sample size of 150 will be block randomised to treatment (receiving the nurse-led transitional care programme and routine post-discharge service) and control groups (receiving routine post-discharge service). The nurse-led transitional care programme comprises of predischarge and follow-up phases with the delivery of bundle of holistic interventions lasting for 8 weeks. There are three timelines for data collection: baseline, immediate post intervention, and 4 weeks post-intervention. Discussion: The findings from this study can potentially inform the development and organisation of post-discharge care and affirm the need for ongoing comprehensive home-based care for burn survivors and their families Trial registration: ClinicalTrials.govNCT04517721. Registered on 20 August 2020
UR - http://www.scopus.com/inward/record.url?scp=85117318032&partnerID=8YFLogxK
U2 - 10.1186/s13063-021-05679-7
DO - 10.1186/s13063-021-05679-7
M3 - Journal article
C2 - 34645512
AN - SCOPUS:85117318032
SN - 1745-6215
VL - 22
JO - Trials
JF - Trials
IS - 1
M1 - 698
ER -